Processa Pharmaceuticals, Inc. Leases Disclosure
Note 6 – Leases
We lease our office space under an operating lease agreement. This lease does not have significant rent escalation, concessions, leasehold improvement incentives, or other build-out clauses. Further, the lease does not contain contingent rent provisions. Our office space lease includes both lease (e.g., fixed payments including rent, taxes, and insurance costs) and non-lease components (e.g., common-area or other maintenance costs), which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. We also lease office equipment under an operating lease. Our leases do not provide an implicit rate and, as such, we have used our incremental borrowing rate of 8% to determine the present value of the lease payments based on the information available at the lease commencement date.
Lease costs included in our consolidated statements of operations totaled $97,000 for the years ended December 31, 2023 and 2022. The weighted average remaining lease terms and discount rate for our operating leases at December 31, 2023 were as follows:
| Remaining lease term (years) for our office lease | 1.8 | |||
| Remaining lease term (years) for our equipment lease | 0.3 | |||
| Weighted average remaining lease term (years) for our facility and equipment leases | 1.7 | |||
| Weighted average discount rate for our facility and equipment leases | 8.0 | % |
Annual lease liabilities for all operating leases were as follows as of December 31, 2023:
| 2024 | $ | 92,389 | ||
| 2025 | 70,040 | |||
| Total lease payments | 162,429 | |||
| Less: Interest | (11,875 | ) | ||
| Present value of lease liabilities | 150,554 | |||
| Less: current maturities | (83,649 | ) | ||
| Non-current lease liability | $ | 66,905 |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2023 | Mar 29, 2024 | Showing above |
| 2022 | Mar 30, 2023 | |
| 2021 | Mar 30, 2022 | |
| 2020 | Mar 25, 2021 | |
| 2019 | Mar 6, 2020 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.